DEA Removes Fenfluramine From Controlled Substances List

The Drug Enforcement Administration is removing fenfluramine from schedule IV of the Controlled Substances Act, it said in a notice of the final rule in the Dec. 23 Federal Register. The DEA said the drug has no abuse potential. The removal eliminates “the regulatory controls and administrative, civil, and criminal sanctions applicable to controlled substances, including those specific to schedule IV controlled substances, on persons who handle (manufacture, distribute, reverse distribute, dispense, engage in research, import, export, conduct instructional activities or chemical analysis with, or possess) or propose to handle fenfluramine,” the DEA said. The delisting is effective Dec. 23.